---
title: "Abbott's Esprit BTK Dissolvable Stent Approved By Health Canada"
description: "Abbott Laboratories has received approval from Health Canada for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed to treat chronic limb threatening ischemia ("
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/259344327.md"
published_at: "2025-09-29T12:37:47.000Z"
---

# Abbott's Esprit BTK Dissolvable Stent Approved By Health Canada

> Abbott Laboratories has received approval from Health Canada for its Esprit BTK Everolimus Eluting Resorbable Scaffold System, a dissolvable stent designed to treat chronic limb threatening ischemia (CLTI) below-the-knee. This device helps keep arteries open and delivers the drug everolimus to aid healing before it fully dissolves, addressing the needs of over 800,000 Canadians suffering from Peripheral Artery Disease (PAD).

Abbott Laboratories (ABT) on Monday announced that Health Canada has approved its dissolvable stent, the Esprit BTK Everolimus Eluting Resorbable Scaffold System.

The device is used to treat people with chronic limb threatening ischemia (CLTI) below-the-knee (BTK). It keeps arteries open and delivers the drug everolimus to support healing before the stent fully dissolves.

More than 800,000 Canadians are living with Peripheral Artery Disease (PAD). CLTI is a severe form of PAD in which arteries become clogged with plaque, blocking blood flow and oxygen to the lower leg and foot. People with CLTI often experience severe pain and non-healing open wounds.

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [ABT.US - Abbott Laboratories](https://longbridge.com/en/quote/ABT.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Key facts: Exact Sciences to merge with Abbott by Q2 2026; 2025 revenue up 18% | Exact Sciences Corp. is merging with Abbott Laboratories, set to finalize in Q2 2026, pending approvals. The company als | [Link](https://longbridge.com/en/news/275986686.md) |
| Is the Market Bullish or Bearish on Abbott Laboratories? | Abbott Laboratories (NYSE:ABT) has seen a 14.02% decrease in short interest, with 15.88 million shares sold short, repre | [Link](https://longbridge.com/en/news/272305312.md) |
| SpaceX launches 12th long-duration crew to International Space Station | SpaceX successfully launched its 12th long-duration crew mission to the International Space Station (ISS) on February 13 | [Link](https://longbridge.com/en/news/275892766.md) |
| ISS A/S kauft insgesamt 15.326.483 Einheiten für 2.906.077.226 DKK im Rahmen des Rückkaufprogramms zurück | ISS A/S has repurchased units worth approximately 2.906 billion DKK as part of its ongoing buyback program. Following th | [Link](https://longbridge.com/en/news/275302046.md) |
| NovaGold Resources (TSE:NG) Director Acquires C$51,160.00 in Stock | NovaGold Resources Inc. (TSE:NG) Director Dawn Patricia Whittaker purchased 4,000 shares at C$12.79 each, totaling C$51, | [Link](https://longbridge.com/en/news/275172548.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.